Czerwińska, K.; Januszewska, L.; Markiewicz-Górka, I.; Jaremków, A.; Martynowicz, H.; Pawlas, K.; Mazur, G.; Poręba, R.; Gać, P.
Selenoprotein P, Peroxiredoxin-5, Renalase and Selected Cardiovascular Consequences Tested in Ambulatory Blood Pressure Monitoring and Echocardiography. Antioxidants 2023, 12, 1187.
https://doi.org/10.3390/antiox12061187
AMA Style
Czerwińska K, Januszewska L, Markiewicz-Górka I, Jaremków A, Martynowicz H, Pawlas K, Mazur G, Poręba R, Gać P.
Selenoprotein P, Peroxiredoxin-5, Renalase and Selected Cardiovascular Consequences Tested in Ambulatory Blood Pressure Monitoring and Echocardiography. Antioxidants. 2023; 12(6):1187.
https://doi.org/10.3390/antiox12061187
Chicago/Turabian Style
Czerwińska, Karolina, Lidia Januszewska, Iwona Markiewicz-Górka, Aleksandra Jaremków, Helena Martynowicz, Krystyna Pawlas, Grzegorz Mazur, Rafał Poręba, and Paweł Gać.
2023. "Selenoprotein P, Peroxiredoxin-5, Renalase and Selected Cardiovascular Consequences Tested in Ambulatory Blood Pressure Monitoring and Echocardiography" Antioxidants 12, no. 6: 1187.
https://doi.org/10.3390/antiox12061187
APA Style
Czerwińska, K., Januszewska, L., Markiewicz-Górka, I., Jaremków, A., Martynowicz, H., Pawlas, K., Mazur, G., Poręba, R., & Gać, P.
(2023). Selenoprotein P, Peroxiredoxin-5, Renalase and Selected Cardiovascular Consequences Tested in Ambulatory Blood Pressure Monitoring and Echocardiography. Antioxidants, 12(6), 1187.
https://doi.org/10.3390/antiox12061187